Getting started
Vaccine Characterisation
Eligibles ttrition plot
Vaccination campaign Characterisation
| CDM name | Cohort name | Variable name | Variable level | Estimate name |
Vaccination campaign
|
||||
|---|---|---|---|---|---|---|---|---|---|
| overall | A_2023 | A_2024 | S_2024 | S_2025 | |||||
| cdm_gold_202507 | vaccine_record | Number records | – | N | 7,399 | 3,548 | 2,391 | 941 | 519 |
| Number subjects | – | N | 3,860 | 3,548 | 2,391 | 941 | 519 | ||
| Cohort start date | – | Median [Q25 - Q75] | 2024-04-19 [2023-10-23 - 2024-10-26] | 2023-10-21 [2023-10-05 - 2023-11-14] | 2024-10-30 [2024-10-15 - 2024-11-19] | 2024-05-03 [2024-04-24 - 2024-05-15] | 2025-04-25 [2025-04-15 - 2025-05-02] | ||
| Range | 2023-09-04 to 2025-05-15 | 2023-09-04 to 2024-01-31 | 2024-09-23 to 2024-12-20 | 2024-04-15 to 2024-06-03 | 2025-04-01 to 2025-05-15 | ||||
| Cohort end date | – | Median [Q25 - Q75] | 2024-04-19 [2023-10-23 - 2024-10-26] | 2023-10-21 [2023-10-05 - 2023-11-14] | 2024-10-30 [2024-10-15 - 2024-11-19] | 2024-05-03 [2024-04-24 - 2024-05-15] | 2025-04-25 [2025-04-15 - 2025-05-02] | ||
| Range | 2023-09-04 to 2025-05-15 | 2023-09-04 to 2024-01-31 | 2024-09-23 to 2024-12-20 | 2024-04-15 to 2024-06-03 | 2025-04-01 to 2025-05-15 | ||||
| Region | London | N (%) | 17 (0.23%) | 13 (0.37%) | – | <5 | – | ||
| Northern ireland | N (%) | 647 (8.74%) | 301 (8.48%) | 214 (8.95%) | 93 (9.88%) | 39 (7.51%) | |||
| Scotland | N (%) | 4,321 (58.40%) | 1,981 (55.83%) | 1,502 (62.82%) | 533 (56.64%) | 305 (58.77%) | |||
| South east | N (%) | 20 (0.27%) | 15 (0.42%) | – | 5 (0.53%) | – | |||
| Wales | N (%) | 2,353 (31.80%) | 1,206 (33.99%) | 675 (28.23%) | 297 (31.56%) | 175 (33.72%) | |||
| West midlands | N (%) | 35 (0.47%) | 26 (0.73%) | – | 9 (0.96%) | – | |||
| Yorkshire & the humber | N (%) | 6 (0.08%) | 6 (0.17%) | – | – | – | |||
| Ethnicity | Asian | N (%) | 33 (0.45%) | 21 (0.59%) | 9 (0.38%) | <5 | <5 | ||
| Black | N (%) | <5 | <5 | <5 | – | – | |||
| White | N (%) | 3,369 (45.53%) | 1,638 (46.17%) | 1,087 (45.46%) | 426 (45.27%) | 218 (42.00%) | |||
| Sex | Female | N (%) | 4,023 (54.37%) | 1,960 (55.24%) | 1,276 (53.37%) | 503 (53.45%) | 284 (54.72%) | ||
| Male | N (%) | 3,376 (45.63%) | 1,588 (44.76%) | 1,115 (46.63%) | 438 (46.55%) | 235 (45.28%) | |||
| Imd | Q1 | N (%) | 1,082 (14.62%) | 469 (13.22%) | 375 (15.68%) | 136 (14.45%) | 102 (19.65%) | ||
| Q2 | N (%) | 1,130 (15.27%) | 564 (15.90%) | 369 (15.43%) | 133 (14.13%) | 64 (12.33%) | |||
| Q3 | N (%) | 2,149 (29.04%) | 1,059 (29.85%) | 641 (26.81%) | 297 (31.56%) | 152 (29.29%) | |||
| Q4 | N (%) | 2,129 (28.77%) | 1,005 (28.33%) | 722 (30.20%) | 258 (27.42%) | 144 (27.75%) | |||
| Q5 | N (%) | 909 (12.29%) | 451 (12.71%) | 284 (11.88%) | 117 (12.43%) | 57 (10.98%) | |||
| Age | – | Median [Q25 - Q75] | 74 [64 - 80] | 69 [60 - 77] | 72 [65 - 78] | 80 [77 - 85] | 81 [78 - 86] | ||
| Mean (SD) | 70.50 (14.53) | 66.98 (15.10) | 69.78 (13.76) | 79.86 (9.27) | 80.95 (8.13) | ||||
| Range | 6 to 105 | 6 to 104 | 7 to 101 | 19 to 105 | 20 to 101 | ||||
| Prior observation | – | Median [Q25 - Q75] | 7,329 [4,178 - 7,996] | 7,178 [3,848 - 7,734] | 7,559 [4,226 - 8,098] | 7,480 [5,147 - 8,126] | 7,829 [4,981 - 8,480] | ||
| Mean (SD) | 6,246.16 (2,863.03) | 6,020.31 (2,804.74) | 6,369.88 (2,919.12) | 6,550.39 (2,764.71) | 6,668.52 (3,041.01) | ||||
| Range | 5 to 13,194 | 6 to 12,830 | 5 to 13,194 | 7 to 12,585 | 20 to 12,897 | ||||
| Future observation | – | Median [Q25 - Q75] | 363 [184 - 554] | 556 [514 - 582] | 189 [167 - 208] | 369 [350 - 384] | 19 [12 - 30] | ||
| Mean (SD) | 347.67 (195.53) | 510.49 (126.50) | 180.73 (38.96) | 338.21 (80.86) | 20.76 (11.25) | ||||
| Range | 1 to 622 | 2 to 622 | 1 to 237 | 11 to 398 | 1 to 46 | ||||
| Days in cohort | – | Median [Q25 - Q75] | 1 [1 - 1] | 1 [1 - 1] | 1 [1 - 1] | 1 [1 - 1] | 1 [1 - 1] | ||
| Mean (SD) | 1.00 (0.00) | 1.00 (0.00) | 1.00 (0.00) | 1.00 (0.00) | 1.00 (0.00) | ||||
| Range | 1 to 1 | 1 to 1 | 1 to 1 | 1 to 1 | 1 to 1 | ||||
| Days to next record | – | Median [Q25 - Q75] | 207 [180 - 370] | 350 [204 - 387] | 187 [175 - 196] | 171 [160 - 184] | – | ||
| Mean (SD) | 262.78 (100.20) | 308.60 (95.39) | 183.23 (19.43) | 175.64 (32.77) | – | ||||
| Range | 92 to 569 | 92 to 569 | 107 to 220 | 119 to 377 | – | ||||
| Number visits in the prior year | – | Median [Q25 - Q75] | 25.00 [15.00 - 38.00] | 24.00 [14.00 - 36.00] | 25.00 [16.00 - 38.00] | 29.00 [19.00 - 41.00] | 30.00 [21.00 - 44.00] | ||
| Mean (SD) | 28.80 (18.93) | 27.27 (19.20) | 28.84 (18.48) | 31.87 (18.86) | 33.51 (17.79) | ||||
| Range | 0.00 to 200.00 | 0.00 to 200.00 | 0.00 to 132.00 | 0.00 to 122.00 | 1.00 to 100.00 | ||||
| Eligibles age | Vaccine record | N (%) | 4,596 (62.12%) | 2,302 (64.88%) | 954 (39.90%) | 853 (90.65%) | 487 (93.83%) | ||
| Eligibles immunosupressed | Vaccine record | N (%) | 128 (1.73%) | 57 (1.61%) | 37 (1.55%) | 22 (2.34%) | 12 (2.31%) | ||
| Number of prior vaccines | Vaccine record | Median [Q25 - Q75] | 4.00 [3.00 - 6.00] | 3.00 [3.00 - 4.00] | 4.00 [4.00 - 6.00] | 6.00 [5.00 - 6.00] | 8.00 [6.00 - 8.00] | ||
| Mean (SD) | 4.31 (1.77) | 3.43 (1.17) | 4.68 (1.76) | 5.29 (1.29) | 6.79 (1.98) | ||||
| Range | 0.00 to 9.00 | 0.00 to 7.00 | 0.00 to 8.00 | 0.00 to 8.00 | 0.00 to 9.00 | ||||
Plots
Overall Vaccination
Vaccination Campaigns
